Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 79

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 79
---
 cannot assure you that the medical facilities in our network
will be able to successfully claim full indemnity from such manufacturers of counterfeit pharmaceutical products.

NewGenIvf also cannot
assure you that the medical facilities in our network will not encounter incidents relating to defective products, or that such
incidents will not materially and adversely affect our network of medical facilities. If the products provided by NewGenIvf’s
suppliers are defective, of poor quality or are otherwise unsafe or ineffective, the medical facilities in NewGenIvf’s network
could be subject to liability claims, complaints or adverse publicity, any of which would materially and adversely affect its
results of operations and reputation. NewGenIvf cannot assure you that the medical facilities in NewGenIvf’s network will find
suitable replacement suppliers on commercially acceptable terms or at all.

<div align='center'>44</div>

The suppliers are also subject
to extensive laws, rules and regulations. If any suppliers violate applicable laws, rules and regulations, NewGenIvf’s reputation
or procurement may be materially and adversely affected. In addition, the medical facilities in NewGenIvf’s network may be exposed
to reputational damages or even liabilities for defective goods provided by the suppliers or negative publicity associated with any suppliers,
and the business and results of operations of the medical facilities in NewGenIvf’s network and NewGenIvf could suffer as a result.

Independent sub-contractors
and/or agents that work with NewGenIvf are also subject to extensive laws, rules, and regulations. If any sub-contractor and/or agent
violates any applicable laws, rules, regulations or breaches any agreements, NewGenIvf’s reputation may be materially and adversely
affected and NewGenIvf may be penalized by regulatory or other parties. In addition, NewgenIvf’s clients may engage Newgen’s
sub-contractors and/or agents for ongoing services or additional services following the termination of contracts with NewGenIvf. NewGenIvf
has no control over the services provided by sub-contractors and cannot assure the quality of such services or ensure compliance with
applicable laws, rules and regulations. In addition, the services provided by independent sub-contractors may expose NewGenIvf to public
scrutiny, adversely affect its brand and reputation, expose it to litigation or regulatory action, and otherwise make its operations vulnerable
if such independent sub-contractors fail to meet their contractual obligations or to comply with applicable laws or regulations